Home Page

In this free webinar, discover strategies for saving capital and reducing time to market in the development and manufacturing of diagnostic and life science consumables. The featured speakers will discuss the purpose-built infrastructure and pilot line capabilities at SCHOTT MINIFAB. Attendees will learn about the benefits of outsourcing, including reduced capital investment and faster time to market. The speakers will also discuss the factors to consider when weighing up the costs of outsourcing vs. insourcing.

TORONTO, April 9, 2024 /PRNewswire-PRWeb/ -- In this webinar, Patrick Tuohy and James Downs will address a critical question encountered by most life science and diagnostic companies: Should the development and/or manufacturing of products be outsourced or in-sourced? The webinar delves into how a leading solutions provider for microfluidic devices and microarray assays can assist companies in saving capital and reducing time to market by outsourcing their development and manufacturing needs.

Business leaders in diagnostic and life science companies grapple with the challenging decision of how to produce their products. By focusing on core competencies, minimizing capital investments and embracing production flexibility, businesses can more efficiently navigate the journey from development to product launch by entering into collaborations.

In this webinar, the expert speakers will explore how life science and diagnostic companies can leverage pilot line capability. This capability consists of purpose-built manufacturing expertise within SCHOTT MINIFAB, enabling the transformation of clients' products from initially assembled units (for feasibility testing) to the first commercial articles that contribute to improving patient health and well-being.

A common objection faced by companies is that insourcing is cheaper than outsourcing. It is crucial to understand the true costs, including those associated with capability development, facilities, equipment, administrative overhead and per capita expenses. In this webinar, the experts will thoroughly consider all relevant factors related to the development and manufacturing of products.

Register for this webinar to discover strategies for saving capital and reducing time to market in the development and manufacturer of diagnostic and life science research consumables.

Join experts from SCHOTT MINIFAB, Dr. James Downs, Business Development Manager, US; and Patrick Tuohy, Business Development Manager, EMEA, for the live webinar on Thursday, April 25, 2024, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Go-To-Market Success: The Role of Capital Preservation in Life Science Research and Diagnostic Consumable Manufacturing.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com

For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com 

View original content to download multimedia:https://www.prweb.com/releases/go-to-market-success-the-role-of-capital-preservation-in-life-science-research-and-diagnostic-consumable-manufacturing-upcoming-webinar-hosted-by-xtalks-302111425.html

SOURCE Xtalks